1. Stocks
  2. Bristol-Myers Squibb Co.
  3. Swot
swot-logo

Bristol-Myers Squibb Co. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Bristol-Myers Squibb Co. has 9 Strengths, 8 Weaknesses, 5 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Relative Outperformance versus Industry over 1 Week

Mid-range Performer (DVM)

PEG lower than Industry PEG

Dividend yield greater than sector dividend yield

Relative Outperformance versus Industry over 1 Week

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Top Gainers

Volume Shockers

Stocks with Quarter Change % less than Industry

PE higher than Industry PE

Companies with High Debt

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Companies with Increasing Debt

Declining Net Cash Flow : Companies not able to generate net cash

Book Value Per Share deteriorating for last 2 years

Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Increased Shareholding in Past Month

Institutions increasing their shareholding

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks